Abstract:Background MicroRNAs (miRNAs) are short, non-coding RNAs (~22 nt) that play important roles in the pathogenesis of human diseases by negatively regulating gene expression. Although miR-196a has been implicated in several other cancers, its role in non-small cell lung cancer (NSCLC) is unknown. The aim of the present study was to examine the expression pattern of miR-196a in NSCLC and its clinical significance, as well as its biological role in tumor progression. Methods Expression of miR-196a was analyzed in 34 NSCLC tissues and five NSCLC cell lines by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The effect of DNA methylation on miR-196a expression was investigated by 5-aza-2-deoxy-cytidine treatment and bisulfite sequencing. The effect of miR-196a on proliferation was evaluated by MTT and colony formation assays, and cell migration and invasion were evaluated by transwell assays. Analysis of target protein expression was determined by western blotting. Luciferase reporter plasmids were constructed to confirm the action of miR-196a on downstream target genes, including HOXA5 . Differences between the results were tested for significance using Student’s t-test (two-tailed). Results miR-196a was highly expressed both in NSCLC samples and cell lines compared with their corresponding normal counterparts, and the expression of miR-196a may be affected by DNA demethylation. Higher expression of miR-196a in NSCLC tissues was associated with a higher clinical stage, and also correlated with NSCLC lymph-node metastasis. In vitro functional assays demonstrated that modulation of miR-196a expression affected NSCLC cell proliferation, migration and invasion. Our analysis showed that miR-196a suppressed the expression of HOXA5 both at the mRNA and protein levels, and luciferase assays confirmed that miR-196a directly bound to the 3’untranslated region of HOXA5. Knockdown of HOXA5 expression in A549 cells using RNAi was shown to promote NSCLC cell proliferation, migration and invasion. Finally, we observed an inverse correlation between HOXA5 and miR-196a expression in NSCLC tissues. Conclusions Our findings indicate that miR-196a is significantly up-regulated in NSCLC tissues, and regulates NSCLC cell proliferation, migration and invasion, partially via the down-regulation of HOXA5. Thus, miR-196a may represent a potential therapeutic target for NSCLC intervention.

MicroRNA-196a Promotes Cervical Cancer Proliferation Through the Regulation of FOXO1 and P27 Kip1

MicroRNA-140-5p Targets Insulin Like Growth Factor 2 Mrna Binding Protein 1 (IGF2BP1) to Suppress Cervical Cancer Growth and Metastasis.

Down-regulation of Microrna-135B Inhibited Growth of Cervical Cancer Cells by Targeting FOXO1.

Micro ribonucleic acid-93 promotes oncogenesis of cervical cancer by targeting RAB11 family interacting protein 1.

Mir-182 Induces Cervical Cancer Cell Apoptosis Through Inhibiting the Expression of DNMT3a.

MicroRNA-196a Promotes Non-Small Cell Lung Cancer Cell Proliferation and Invasion Through Targeting HOXA5

Mir-130A-3p Promotes Cell Proliferation and Invasion by Targeting Estrogen Receptor Α and Androgen Receptor in Cervical Cancer.

MiR-200b Promotes the Cell Proliferation and Metastasis of Cervical Cancer by Inhibiting FOXG1.

MiR-196a is Upregulated in Gastric Cancer and Promotes Cell Proliferation by Downregulating P27(kip1).

1069 MicroRNA-143 is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer

MicroRNA-196a Promotes Cell Proliferation and Inhibits Apoptosis in Human Ovarian Cancer by Directly Targeting DDX3 and Regulating the PTEN/PI3K/AKT Signaling Pathway

Investigating the Role and Mechanism of Microrna-196A in Oral Squamous Cell Carcinoma by Targeting FOXO1

Up-regulated miR-196a promotes non-small cell lung cancer cells proliferation by regulating p27~(kip1) expression

miR-196a targeting LRIG3 promotes the proliferation and migration of cervical cancer cells

miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer

Upregulation of MiR-196a Promotes Cell Proliferation by Downregulating P27kip1 in Laryngeal Cancer

MicroRNA-543 Acts As a Prognostic Marker and Promotes the Cell Proliferation in Cervical Cancer by BRCA1-interacting Protein 1.

Mir-135a Enhances Cellular Proliferation Through Post-Transcriptionally Regulating PHLPP2 and FOXO1 in Human Bladder Cancer

MicroRNA-133b is a Key Promoter of Cervical Carcinoma Development Through the Activation of the ERK and AKT1 Pathways.

MiR-146a-5p Inhibits Proliferation and Promotes Apoptosis of Oral Squamous Cell Carcinoma Cells by Regulating NF-κB Signaling Pathway

Tumor Suppressive Microrna-193B Promotes Breast Cancer Progression Via Targeting DNAJC13 and RAB22A.